Vyome Holdings, Inc (HIND): Depreciation & Amortization
$12.0K
Year ended 2025-12-31
$10.7K
Trailing 12 months to 2026-06-30
-48.8%
5-year compound annual growth
-23.2%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.0K | -30.9% | 2026-03-18, From 2025-01-01 |
| 2024-12-31 | $17.3K | n/a | 2026-03-18, From 2024-01-01 |
| No annual figure between 2020-12-31 and 2024-12-31. | |||
| 2020-12-31 | $340.0K | -29.0% | 2021-03-12, From 2020-01-01 |
| 2019-12-31 | $479.0K | n/a | 2021-03-12, From 2019-01-01 |
| No annual figure between 2017-12-31 and 2019-12-31. | |||
| 2017-12-31 | $330.0K | +71.9% | 2018-03-05, From 2017-01-01 |
| 2016-12-31 | $192.0K | +15.0% | 2018-03-05, From 2016-01-01 |
| 2015-12-31 | $167.0K | +0.6% | 2018-03-05, From 2015-01-01 |
| 2014-12-31 | $166.0K | n/a | 2017-02-23, From 2014-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $12.0K | -30.9% |
| Allarity Therapeutics, Inc. (ALLR) | 2024-12-31 | $9.0K | -75.7% |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $24.0K | +242.9% |
| Medicinova Inc (MNOV) | 2025-12-31 | $20.1K | -4.6% |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $491.8K | n/a |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $2.9K | +71.3% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $615.7K | -11.6% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $23.0K | +475.0% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $96.1K | n/m |
Compare HIND, ALLR, CANF, MNOV side by side · Screen every company in Pharmaceutical Preparations ↗